Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio
Status: Enrolling
Updated:  5/11/2017
mi
from
Cincinnati, OH
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio
Status: Enrolling
Updated: 5/11/2017
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Virtual Occupational Therapy Application
Virtual Occupational Therapy Application
Status: Enrolling
Updated:  5/16/2017
mi
from
Charlottesville, VA
Virtual Occupational Therapy Application
Virtual Occupational Therapy Application
Status: Enrolling
Updated: 5/16/2017
UVA- HealthSouth Rehabilitation Hospital
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
Status: Enrolling
Updated:  5/17/2017
mi
from
Saint Petersburg, FL
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
Status: Enrolling
Updated: 5/17/2017
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Status: Enrolling
Updated:  5/17/2017
mi
from
Denver, CO
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Status: Enrolling
Updated: 5/17/2017
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Status: Enrolling
Updated:  5/18/2017
mi
from
Stanford, CA
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity
Status: Enrolling
Updated: 5/18/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Acupressure and Stress Resilience
Using Complementary and Alternative Medicine (CAM) to Promote Stress Resilience in Those With Co-Occurring Mild TBI and PTSD
Status: Enrolling
Updated:  5/18/2017
mi
from
Denver, CO
Acupressure and Stress Resilience
Using Complementary and Alternative Medicine (CAM) to Promote Stress Resilience in Those With Co-Occurring Mild TBI and PTSD
Status: Enrolling
Updated: 5/18/2017
Denver VAMC
mi
from
Denver, CO
Click here to add this to my saved trials
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Status: Enrolling
Updated:  5/18/2017
mi
from
Philadelphia, PA
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations
Status: Enrolling
Updated: 5/18/2017
Penn Medicine Rittenhouse
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
A Pilot Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Status: Enrolling
Updated:  5/19/2017
mi
from
Indianapolis, IN
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
A Pilot Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 5/19/2017
Riley Hospital, Riley Child and Adolescent Psychiatry Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Genetic Contributions to Autism Spectrum Disorders
Genetic Contributions to Autism Spectrum Disorders
Status: Enrolling
Updated:  5/30/2017
mi
from
Boston, MA
Genetic Contributions to Autism Spectrum Disorders
Genetic Contributions to Autism Spectrum Disorders
Status: Enrolling
Updated: 5/30/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)
Randomized Controlled Pilot Trial of Adjunct Group Acupuncture vs Usual Care Among Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  5/30/2017
mi
from
San Francisco, CA
Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)
Randomized Controlled Pilot Trial of Adjunct Group Acupuncture vs Usual Care Among Patients With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 5/30/2017
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Staccato Loxapine in Agitation (Proof of Concept)
A Multi-center, Randomized, Double-blind, Placebo-controlled, Single Dose Efficacy and Safety Study of StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
Status: Enrolling
Updated:  5/30/2017
mi
from
Upland, CA
Staccato Loxapine in Agitation (Proof of Concept)
A Multi-center, Randomized, Double-blind, Placebo-controlled, Single Dose Efficacy and Safety Study of StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
Status: Enrolling
Updated: 5/30/2017
Pacific Clinical Research Medical Group, 1317 West Foothill Blvd, Suite 200
mi
from
Upland, CA
Click here to add this to my saved trials
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  6/5/2017
mi
from
San Diego, CA
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 6/5/2017
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Severe Traumatic Brain Injury, A Pilot Randomized Clinical Trial Using Propranolol and Clonidine
Status: Enrolling
Updated:  6/7/2017
mi
from
Nashville, TN
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Severe Traumatic Brain Injury, A Pilot Randomized Clinical Trial Using Propranolol and Clonidine
Status: Enrolling
Updated: 6/7/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Birmingham, AL
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Clinical research Center of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Little Rock, AR
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Arkansas Children's Hosptial
mi
from
Little Rock, AR
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Huntington Beach, CA
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Pediatric Care Medical Group, Inc
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Los Angeles, CA
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Orange, CA
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Choc Psf, Amc
mi
from
Orange, CA
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Roseville, CA
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Allergy Medical Group of the North Area
mi
from
Roseville, CA
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
San Diego, CA
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Allergy & Asthma Medical Group & Research Center A.P.C.
mi
from
San Diego, CA
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Centennial, CO
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
1st Allergy and Clinical Research Group, INC, d/b/a IMMUNOe International Research Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Normal, IL
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Sneeze, Wheeze & Itch Associates LLC
mi
from
Normal, IL
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Chevy Chase, MD
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Institute for Allergy and Asthma
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Silver Spring, MD
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Einstein Consulting Services, LLC & Virgo Carter Pediatrics
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Plymouth, MN
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Clinical Research Institute Inc
mi
from
Plymouth, MN
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Middleburg Heights, OH
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Clinical Research Solutions, LLC
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Orangeburg, SC
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Carolina Ear, Nose and Throat Clinic
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Boerne, TX
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
TTS Research
mi
from
Boerne, TX
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Seattle, WA
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
Oklahoma City, OK
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated:  6/7/2017
mi
from
San Antonio, TX
Formula for Children With Cow's Milk Allergy
A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein
Status: Enrolling
Updated: 6/7/2017
STAAMP Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated:  6/14/2017
mi
from
Paoli, PA
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated: 6/14/2017
Paoli Memorial Hospital
mi
from
Paoli, PA
Click here to add this to my saved trials
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated:  6/14/2017
mi
from
Philadelphia, PA
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy
Status: Enrolling
Updated: 6/14/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"
"A Randomized, Controlled, Trial of Interactive Metronome Technology for Remediation of Cognitive Difficulties Following Blast-Related Traumatic Brain Injury"
Status: Enrolling
Updated:  6/19/2017
mi
from
Colorado Springs, CO
"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"
"A Randomized, Controlled, Trial of Interactive Metronome Technology for Remediation of Cognitive Difficulties Following Blast-Related Traumatic Brain Injury"
Status: Enrolling
Updated: 6/19/2017
Warrior Recovery Center
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Optimizing Drug Doses in Critically Ill
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated:  6/19/2017
mi
from
Lexington, KY
Optimizing Drug Doses in Critically Ill
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated: 6/19/2017
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Optimizing Drug Doses in Critically Ill
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated:  6/19/2017
mi
from
Chapel Hill, NC
Optimizing Drug Doses in Critically Ill
Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients
Status: Enrolling
Updated: 6/19/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
ARTSS-IA: A Pilot, Phase IIa, Safety and Feasibility Study of ARgatroban in Combination With Recombinant Tissue Plasminogen Activator Stroke Study - Intra-Arterial
Status: Enrolling
Updated:  6/20/2017
mi
from
Houston, TX
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
ARTSS-IA: A Pilot, Phase IIa, Safety and Feasibility Study of ARgatroban in Combination With Recombinant Tissue Plasminogen Activator Stroke Study - Intra-Arterial
Status: Enrolling
Updated: 6/20/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Depotentiation in People With Focal Hand Dystonia
Depotentiation in Focal Hand Dystonia Patients
Status: Enrolling
Updated:  6/21/2017
mi
from
Bethesda, MD
Depotentiation in People With Focal Hand Dystonia
Depotentiation in Focal Hand Dystonia Patients
Status: Enrolling
Updated: 6/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Status: Enrolling
Updated:  6/26/2017
mi
from
Minneapolis, MN
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity
Status: Enrolling
Updated: 6/26/2017
University of Minnesota Clinical and Translational Science Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Status: Enrolling
Updated:  6/26/2017
mi
from
Minneapolis, MN
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
Status: Enrolling
Updated: 6/26/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Simulated Home Therapy Program for the Hand After Stroke
Simulated Home Therapy Program for the Hand After Stroke
Status: Enrolling
Updated:  6/26/2017
mi
from
Chicago, IL
Simulated Home Therapy Program for the Hand After Stroke
Simulated Home Therapy Program for the Hand After Stroke
Status: Enrolling
Updated: 6/26/2017
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Protein Supplementation in Infants With Brain Injury
Protein Supplementation in Infants With Brain Injury
Status: Enrolling
Updated:  7/5/2017
mi
from
Cincinnati, OH
Protein Supplementation in Infants With Brain Injury
Protein Supplementation in Infants With Brain Injury
Status: Enrolling
Updated: 7/5/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder
Randomized Control Trial of Two Computer-Based Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/6/2017
mi
from
Boston, MA
Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder
Randomized Control Trial of Two Computer-Based Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/6/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated:  7/10/2017
mi
from
Rochester, NY
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
aTyr Pharma Investigative Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated:  7/10/2017
mi
from
Columbus, OH
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
aTyr Pharma Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated:  7/10/2017
mi
from
Marseille,
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy
A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Biological Activity of ATYR1940 in Adult Patients With Molecularly Defined Genetic Muscular Dystrophies
Status: Enrolling
Updated: 7/10/2017
aTyr Pharma Investigative Site
mi
from
Marseille,
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
mi
from
Birmingham, AL
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
mi
from
Des Moines, IA
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Drake University
mi
from
Des Moines, IA
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
mi
from
Iowa City, IA
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
mi
from
Kansas City, KA
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
University of Kansas
mi
from
Kansas City, KA
Click here to add this to my saved trials